BLACK DIAMOND THERAPEUTICS
Live / Registered — Registered (as of 17 Nov 2020)
What this means for you
Registered since 17 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88564765
- Registration number
- 6198088
- Mark type
- Design + words
- Filed
- 02 Aug 2019
- Published for opposition
- 01 Sept 2020
- Registered
- 17 Nov 2020
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research services in connection with identifying genes and biomarkers relevant for cancer; Pharmaceutical research and development services; research and development services in the field of diagnostic tools and tests for identifying patients with genetic mutations or biomarkers relevant to oncology treatment
Owner
- Black Diamond Therapeutics, Inc., Cambridge, MA, US
- Black Diamond Therapeutics, Inc., Cambridge, MA, US
- Black Diamond Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 17 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Nov 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Nov 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Nov 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Nov 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Nov 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 01 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Sept 2020 — PUBLISHED FOR OPPOSITION
- 12 Aug 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Jul 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jul 2020 — EXAMINER'S AMENDMENT ENTERED
- 29 Jul 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 Jul 2020 — EXAMINERS AMENDMENT E-MAILED
- 29 Jul 2020 — EXAMINERS AMENDMENT -WRITTEN